OPKO HealthLTS:0KCS +3.36%53 PB Ratio is 0.97 as of Jun. 29, 2026, which is 2% above its 10-year median of 0.95. GuruFocus rates LTS:0KCS with a GF Score™ of 53/100 and a GF Value™ of $1.07 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 196 Medical Diagnostics & Research companies, OPKO Health ranks better than 82.14% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), OPKO Health's share price is $1.54. OPKO Health's Book Value per Share for the quarter that ended in Mar. 2026 was $1.60. Hence, OPKO Health's PB Ratio of today is 0.97.
Warning Sign:
OPKO Health Inc stock PB Ratio (=0.95) is close to 2-year high of 0.95.
The historical rank and industry rank for OPKO Health's PB Ratio or its related term are showing as below:
LTS:0KCS'
s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 0.95 Max: 3.15
Current: 0.95
During the past 13 years, OPKO Health's highest PB Ratio was 3.15. The lowest was 0.49. And the median was 0.95.
LTS:0KCS's PB Ratio is ranked better than 82.14% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.04
vs LTS:0KCS: 0.95
During the past 12 months, OPKO Health's average Book Value Per Share Growth Rate was -18.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of OPKO Health was 546.70% per year. The lowest was -88.50% per year. And the median was -5.75% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
OPKO Health PB Ratio Related Terms
OPKO Health PB Ratio Historical Data
* Premium members only.
The historical data trend for OPKO Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, OPKO Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OPKO Health PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where OPKO Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
OPKO Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
OPKO Health (LTS:0KCS) has a PB Ratio of 0.97 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on OPKO Health and its competitors. This is near median its historical median of 0.95. Over the past decade, OPKO Health's PB Ratio has ranged from 0.49 to 3.15. According to the industry distribution chart, OPKO Health ranks #35 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 17.9%.
Is OPKO Health's PB Ratio too high?
OPKO Health's current PB Ratio of 0.97 is near median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 3.15. The Medical Diagnostics & Research industry median PB Ratio is 2.04. OPKO Health's value of 0.97 is 52.5% below this industry median. Based on the distribution chart, OPKO Health ranks #35 out of 196 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, OPKO Health has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's PB Ratio compare to PSNL and CDNA?
According to the Medical Diagnostics & Research industry distribution chart, OPKO Health ranks #35 out of 196 companies for PB Ratio. This places OPKO Health in the top 18% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.04. OPKO Health's value of 0.97 is 52.5% below this benchmark. Historically, OPKO Health's own PB Ratio has ranged from 0.49 to 3.15 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 2.04, OPKO Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.04, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OPKO Health's current PB Ratio of 0.97 is 52.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on OPKO Health and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OPKO Health's current PB Ratio is 0.97, which is near median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (LTS:0KCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.07, compared to a current price of $1.54 — trading 43.9% above its estimated fair value. The current PB Ratio is 0.97, which is near median its 10-year median of 0.95 and 52.5% below the Medical Diagnostics & Research industry median of 2.04. OPKO Health's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For OPKO Health (LTS:0KCS), the current PB Ratio is 0.97 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OPKO Health (LTS:0KCS) Overvalued in 2026?
Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued.
The current stock price of $1.54 is trading 43.9% above its estimated GF Value™ of $1.07.
GuruFocus considers OPKO Health to be Significantly Overvalued.
Key valuation signals for LTS:0KCS:
PB Ratio: 0.97 (near median its 10-year median of 0.95)
GF Value™: $1.07 vs. price of $1.54 (43.9% above fair value)
Industry Position: 52.5% below the Medical Diagnostics & Research median (#35 of 196)
No single metric tells the full story. See the LTS:0KCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
53GF Score
Get the complete analysis for LTS:0KCS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0KCS has been successfully added to your 
